NOL6 Promotes the Proliferation and Migration of Endometrial Cancer Cells by Regulating TWIST1 Expression

References

• Urick ME , BellDW. Clinical actionability of molecular targets in endometrial cancer. Nat. Rev. Cancer19(9), 510–521 (2019).
   PubMed Web of Science ®Google Scholar
• Setiawan VW , YangHP , PikeMCet al. Type I and II endometrial cancers: have they different risk factors? J. Clin. Oncol. 31(20), 2607–2618 (2013).
   PubMed Web of Science ®Google Scholar
• Andersen JS , LyonCE , FoxAHet al. Directed proteomic analysis of the human nucleolus. Curr. Biol.12(1), 1–11 (2002).
   PubMed Web of Science ®Google Scholar
• Buchwalter A , HetzerMW. Nucleolar expansion and elevated protein translation in premature aging. Nat. Commun.8(1), 328 (2017).
   PubMedGoogle Scholar
• Orsolic I , JuradaD , PullenN , OrenM , EliopoulosAG , VolarevicS. The relationship between the nucleolus and cancer: current evidence and emerging paradigms. Semin. Cancer Biol.37(38), 36–50 (2016).
   PubMedGoogle Scholar
• Penzo M , MontanaroL , TreréD , DerenziniM. The ribosome biogenesis–cancer connection. Cells8(1), 55 (2019).
   PubMed Web of Science ®Google Scholar
• Utama B , KennedyD , RuK , MattickJS. Isolation and characterization of a new nucleolar protein, Nrap, that is conserved from yeast to humans. Genes Cells7(2), 115–132 (2002).
   PubMed Web of Science ®Google Scholar
• Fuhrman LE , GoelAK , SmithJ , ShiannaKV , AballayA. Nucleolar proteins suppress Caenorhabditis elegans innate immunity by inhibiting p53/CEP-1. PLoS Genet.5(9), e1000657 (2009).
   PubMed Web of Science ®Google Scholar
• Eswara MB , ClaytonA , MangrooD. Utp22p acts in concert with Utp8p to channel aminoacyl-tRNA from the nucleolus to the nuclear tRNA export receptor Los1p but not Msn5p. Biochem. Cell Biol.90(6), 731–749 (2012).
   PubMedGoogle Scholar
• Dong D , SongM , WuX , WangW. NOL6, a new founding oncogene in human prostate cancer and targeted by miR-590-3p. Cytotechnology72(3), 469–478 (2020).
   PubMed Web of Science ®Google Scholar
• Zhang H , LiM , ZhengX , SunY , WenZ , ZhaoX. Endometriotic stromal cells lose the ability to regulate cell-survival signaling in endometrial epithelial cells in vitro. Mol. Hum. Reprod.15(10), 653–663 (2009).
   PubMed Web of Science ®Google Scholar
• Fujimura A , HayashiY , KatoKet al. Identification of a novel nucleolar protein complex required for mitotic chromosome segregation through centromeric accumulation of Aurora B. Nucleic Acids Res.48(12), 6583–6596 (2020).
   PubMed Web of Science ®Google Scholar
• Hong J , LeeJH , ChungIK. Telomerase activates transcription of cyclin D1 gene through an interaction with NOL1. J. Cell Sci.129(8), 1566–1579 (2016).
   PubMed Web of Science ®Google Scholar
• Gu S , HouP , LiuKet al. NOL8, the binding protein for beta-catenin, promoted the growth and migration of prostate cancer cells. Chem. Biol. Interact.294, 40–47 (2018).
   PubMed Web of Science ®Google Scholar
• Lin TC , SuCY , WuPYet al. The nucleolar protein NIFK promotes cancer progression via CK1α/β-catenin in metastasis and Ki-67-dependent cell proliferation. eLife5, e11288 (2016).
   PubMed Web of Science ®Google Scholar
• Demokan S , ChuangAY , PattaniKM , SidranskyD , KochW , CalifanoJA. Validation of nucleolar protein 4 as a novel methylated tumor suppressor gene in head and neck cancer. Oncol. Rep.31(2), 1014–1020 (2014).
   PubMed Web of Science ®Google Scholar
• Rahman MR , IslamT , ZamanTet al. Identification of molecular signatures and pathways to identify novel therapeutic targets in Alzheimer’s disease: insights from a systems biomedicine perspective. Genomics112(2), 1290–1299 (2020).
   PubMed Web of Science ®Google Scholar
• Wei SC , FattetL , TsaiJHet al. Matrix stiffness drives epithelial-mesenchymal transition and tumour metastasis through a TWIST1–G3BP2 mechanotransduction pathway. Nat. Cell Biol.17(5), 678–688 (2015).
   PubMed Web of Science ®Google Scholar
• Yang-Hartwich Y , TedjaR , RobertsCMet al. p53-Pirh2 complex promotes TWIST1 degradation and inhibits EMT. Mol. Cancer Res.17(1), 153–164 (2019).
   PubMed Web of Science ®Google Scholar
• Fang YY , TanMR , ZhouJet al. miR-214-3p inhibits epithelial-to-mesenchymal transition and metastasis of endometrial cancer cells by targeting TWIST1. Oncotargets Ther.12, 9449–9458 (2019).
   PubMed Web of Science ®Google Scholar
• Qin Q , XuY , HeT , QinC , XuJ. Normal and disease-related biological functions of TWIST1 and underlying molecular mechanisms. Cell Res.22(1), 90–106 (2012).
   PubMed Web of Science ®Google Scholar
• Shen J , ChenQ , LiN , BaiX , WangF , LiB. TWIST1 expression and clinical significance in type I endometrial cancer and premalignant lesions: a retrospective clinical study. Medicine99(48), e23397 (2020).
   PubMed Web of Science ®Google Scholar
• Liu W , ZhangB , XuN , WangMJ , LiuQ. miR-326 regulates EMT and metastasis of endometrial cancer through targeting TWIST1. Eur. Rev. Med. Pharmacol.21(17), 3787–3793 (2017).
   PubMed Web of Science ®Google Scholar
• Nieto MA , HuangRY , JacksonRA , ThieryJP. EMT: 2016. Cell166(1), 21–45 (2016).
   PubMed Web of Science ®Google Scholar
• Wilson MR , ReskeJJ , HolladayJet al. ARID1A and PI3-kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion. Nat. Commun.10(1), 3554 (2019).
   PubMedGoogle Scholar
• Hoxhaj G , ManningBD. The PI3K-AKT network at the interface of oncogenic signalling and cancer metabolism. Nat. Rev. Cancer20(2), 74–88 (2020).
   PubMed Web of Science ®Google Scholar
• Liu J , EckertMA , HaradaBTet al. m6A mRNA methylation regulates AKT activity to promote the proliferation and tumorigenicity of endometrial cancer. Nat. Cell. Biol.20(9), 1074–1083 (2018).
   PubMed Web of Science ®Google Scholar
• Slomovitz BM , ColemanRL. The PI3K/AKT/mTOR pathway as a therapeutic target in endometrial cancer. Clin. Cancer Res.18(21), 5856–5864 (2012).
   PubMed Web of Science ®Google Scholar
• Xue G , RestucciaDF , LanQet al. Akt/PKB-mediated phosphorylation of TWIST1 promotes tumor metastasis via mediating cross-talk between PI3K/Akt and TGF-β signaling axes. Cancer Discov.2(3), 248–259 (2012).
   PubMed Web of Science ®Google Scholar
• Weiss MB , AbelEV , MayberryMM , BasileKJ , BergerAC , AplinAE. TWIST1 is an ERK1/2 effector that promotes invasion and regulates MMP-1 expression in human melanoma cells. Cancer Res.72(24), 6382–6392 (2012).
   PubMed Web of Science ®Google Scholar
• Caunt CJ , SaleMJ , SmithPD , CookSJ. MEK1 and MEK2 inhibitors and cancer therapy: the long and winding road. Nat. Rev. Cancer15(10), 577–592 (2015).
   PubMed Web of Science ®Google Scholar
• Kim TH , YooJY , KimHIet al. Mig-6 suppresses endometrial cancer associated with PTEN deficiency and ERK activation. Cancer Res.74(24), 7371–7382 (2014).
   PubMed Web of Science ®Google Scholar